The role and therapeutic potential of mitophagy in major depressive disorder

Area of Science:

• Neuroscience
• Cell Biology
• Molecular Biology

Background:

• Major depressive disorder (MDD) impacts over 264 million globally, with limited efficacy of traditional treatments.
• Exploring novel therapeutic avenues is critical for managing this prevalent health challenge.
• Mitophagy, a selective form of autophagy, is increasingly recognized for its potential role in MDD pathogenesis.

Purpose of the Study:

• To elucidate the molecular mechanisms of mitophagy in the context of MDD.
• To investigate the associations between mitophagy and key MDD-related factors including neuroinflammation, oxidative stress, neurotransmitter synthesis, and neuroplasticity.
• To review clinical research progress and therapeutic strategies targeting mitophagy for MDD.

Main Methods:

• Focus on proteins and molecular pathways involved in mitophagy.
• Analysis of the interplay between mitophagy and neurobiological processes implicated in MDD.
• Review of existing literature on clinical studies and interventions modulating mitophagy.

Main Results:

• Mitophagy is intricately linked to neuroinflammation, oxidative stress, neurotransmitter balance, and neuroplasticity in MDD.
• Current research highlights the potential of mitophagy modulation as a therapeutic strategy for MDD.
• Both pharmaceutical and non-pharmaceutical interventions targeting mitophagy are being explored.

Conclusions:

• Mitophagy plays a significant role in the pathogenesis of major depressive disorder.
• Targeting mitophagy offers a promising scientific basis for developing novel MDD treatments.
• Further clinical research is needed to fully realize the therapeutic potential of mitophagy-based strategies.